Lv4
790 积分 2026-01-21 加入
Optimal adjuvant radiotherapy strategy for cervical cancer: a multi-center database cohort study
3个月前
已完结
A modified diffusion-weighted magnetic resonance imaging–based model from the radiologist’s perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer
3个月前
已完结
Centromere Protein F Is a Potential Prognostic Biomarker and Target for Cutaneous Melanoma
5个月前
已完结
CD34+CLDN5+ tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma
5个月前
已完结
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
5个月前
已完结
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma
5个月前
已关闭
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
5个月前
已完结
Clinicopathological and molecular correlates of clinical benefit from disitamab vedotin (RC48), a HER-2-targeting antibody-drug conjugate, in metastatic urothelial carcinoma: a multi-center, real-world study
5个月前
已完结
Natural killer cell infiltration elicits gender‐dependent dichotomous clinical outcomes in urothelial carcinoma
5个月前
已完结
Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo)
5个月前
已完结
皖公网安备34019202002308
